Placebo Task Clinical Trial
Official title:
Studying a Novel Intervention, the Tobacco Retraining of Automatic Approach (TRAA), to Treat Individuals With Tobacco Dependence and Severe Concurrent Disorders
NCT number | NCT01902199 |
Other study ID # | H13-01422 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | October 2014 |
Est. completion date | December 2015 |
Verified date | June 2021 |
Source | University of British Columbia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A randomized control trial evaluating a novel smoking cessation intervention in individuals at a an inpatient clinic for clients with addiction and concurrent disorders. The intervention is based on cognitive bias modification, where participants are explicitly or implicitly trained to make avoidance movements by pushing a joystick in response to pictures of smoking, and as a result altering their cognitive biases towards smoking and tobacco dependence. Hypothesis: Participation in the experimental (tobacco-avoidance) condition will induce reduction of smoking, assessed as lower levels of carbon monoxide measured at baseline and 12 week follow-up.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | December 2015 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - Proficiency to read and write english - A minimum score of 5 or higher on the fagerström test for nicotine dependence, indicating a medium dependence - Current smoking will be validated by Carbon monoxide breath monitor Exclusion Criteria: - Patients not yet stabilized enough to allow for regular participation in the intervention |
Country | Name | City | State |
---|---|---|---|
Canada | Burnaby Centre for Mental Health and Addiction | Burnaby | British Columbia |
Lead Sponsor | Collaborator |
---|---|
University of British Columbia | Provincial Health Services Authority |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Carbon monoxide levels in breath | The breath carbon monoxide monitoring device will be used both before the intervention for a baseline measure and at the 12-week follow-up for comparison. These two measurements will be used to detect changes in smoking patterns that may have occurred during this interval. The method allows to objectify abstinence from smoking. | baseline, 12 weeks | |
Secondary | Fagerström test for Nicotine dependence (FTND) | The FTND is a 6-item questionnaire scored to test level of nicotine dependence, and will be presented to patients prior to the intervention. Patients meeting a cut-off score of 5 or higher will be eligible to participate in the intervention portion of this study. | Baseline |